Revance Therapeutics, Inc.

Report date
12/31/2024
Quarter
2024 Q4
Filed
2/14/2025
Shares
170,136
Value ($000)
517
Weight
0.0%
2019 Q4 - 2024 Q4 (15 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).